The Hemp Economic Mobilization Plan Act of 2025 (the HEMP Act of 2025) would amend the Agricultural Marketing Act of 1946 to change the federal definition of hemp. The bill raises the allowable delta-9 tetrahydrocannabinol (THC) threshold for hemp from 0.3 percent to 1 percent on a dry-weight basis, and makes conforming changes throughout the hemp production provisions of federal law. It also updates related testing language to require methods with a measurement of uncertainty no greater than 0.075 percent and clarifies references to products derived from hemp plants.
The bill adds new transportation documentation requirements for hemp shipments. Under both state/tribal hemp plans and the U.S. Department of Agriculture’s federal plan, anyone transporting hemp would need to keep with the shipment either proof of a valid producer license/authorization or a laboratory certificate showing the hemp contains no more than 1 percent delta-9 THC. The bill also directs the Secretary of Agriculture to revise USDA hemp regulations within 90 days of enactment, without going through the usual notice-and-comment process, to conform the regulations to the new statutory changes.
Its main legal effect would be to broaden the category of cannabis plants and products that qualify as hemp under federal law, potentially reducing the number of crops and shipments treated as marijuana or otherwise noncompliant under federal hemp rules. This would affect hemp producers, processors, transporters, state agriculture departments, tribal governments, laboratories, and USDA enforcement and licensing programs. Because the bill amends the federal hemp framework, it could also influence downstream state hemp programs that mirror federal standards.
The available context shows no recorded committee debate or votes, so there is no documented floor or committee sentiment in the provided materials. Based on the bill text alone, the measure appears industry-friendly and deregulatory for hemp growers and transporters, while imposing some additional documentation and testing requirements to support enforcement. The main likely point of contention is the higher THC threshold: supporters may view it as modernizing hemp policy and improving economic viability, while critics may worry it blurs the line between hemp and intoxicating cannabis products and complicates enforcement.
Impact
The bill would amend 7 U.S.C. 1639o and 1639p-1639q in the Agricultural Marketing Act of 1946 to redefine hemp from 0.3 percent to 1 percent delta-9 THC and to revise related testing, licensing, and transport documentation rules. It would require USDA to update 7 C.F.R. part 990 within 90 days, affecting federal hemp regulations and likely state and tribal hemp plans that operate under the federal framework.
Sentiment
No committee transcript or vote record was provided, so there is no direct evidence of legislative sentiment in the available context. The bill’s structure suggests a generally supportive posture toward hemp producers and the hemp industry, paired with compliance-oriented safeguards for testing and shipment documentation.
Contention
The central point of contention is the proposed increase in the hemp THC limit from 0.3 percent to 1 percent. Supporters are likely to argue that the change reflects practical cultivation realities and reduces crop losses, while opponents may argue it weakens the distinction between hemp and marijuana and could create enforcement and public-safety concerns. Secondary issues include the new transport paperwork requirements and the expedited regulatory revision mandate, which may be viewed as either necessary guardrails or added administrative burden.
Relating to the regulation of hemp and nonconsumable hemp products; increasing a criminal penalty; increasing a civil penalty and providing other penalties; requiring an occupational license; imposing and authorizing certain fees.
Continuing Appropriations Act, 2026 Legislative Branch Appropriations Act, 2026 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026 Over-the-Counter Monograph Drug User Fee Amendments